Platinum Investment Management Ltd Q4 2022 vs. Q1 2023 13F Holdings Comparison

Platinum Investment Management Ltd, a global investment manager headquartered in London, England, recently filed its latest Securities and Exchange Commission (SEC) 13F quarterly report. The report details its holdings as of the end of Q4 2022 and those at the end of Q1 2023. In this blog post, we'll analyze Platinum Investment Management Ltd's latest 13F filings, compare its Q4 2022 and Q1 2023 holdings, and discuss its top buys and sells.

Platinum Investment Management Ltd Q4 2022 vs. Q1 2023 Holdings Comparison

According to the latest 13F filings, the total value of Platinum Investment Management Ltd's 13F portfolio decreased from $3.1 billion in Q4 2022 to $2.9 billion in Q1 2023, representing a decrease of 6.5%. The number of positions in the portfolio decreased from 79 to 63. Of the 63 stocks in the portfolio, 30 stocks were increased, 25 stocks were decreased, and 8 stocks were unchanged.

Top Purchases

The top purchases of Platinum Investment Management Ltd in Q1 2023 were:

1. Transunion (TRU)

2. Meta Platforms Inc (META)

3. Nanostream Technologies (NSTG)

4. Omega Therapeutics Inc (OMGA)

5. Adaptative Biotechnologies Corp (ADPT)

Top Sales

The top sales of Platinum Investment Management Ltd in Q1 2023 were:

1. Booking Holdings Inc (BKNG)

2. Suzano S A (SUZ)

3. Suncor Energy Inc New (SU.TO)

4. JD.com Inc (JD)

5. Carlsile Cos Inc (CSL)

Conclusion

In conclusion, Platinum Investment Management Ltd's 13F portfolio saw a decrease in value and a decrease in the number of positions in Q1 2023. Platinum Investment Management Ltd added several new stocks to its portfolio, including Nanostream Technologies and Omega Therapeutics Inc. We'll continue to monitor the holdings of Platinum Investment Management Ltd and report back on any significant changes in its 13F portfolio in our next update.